IL150100A0 - Pharmaceutical compositions containing fused cyclic compounds - Google Patents

Pharmaceutical compositions containing fused cyclic compounds

Info

Publication number
IL150100A0
IL150100A0 IL15010001A IL15010001A IL150100A0 IL 150100 A0 IL150100 A0 IL 150100A0 IL 15010001 A IL15010001 A IL 15010001A IL 15010001 A IL15010001 A IL 15010001A IL 150100 A0 IL150100 A0 IL 150100A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
cyclic compounds
containing fused
fused cyclic
Prior art date
Application number
IL15010001A
Other languages
English (en)
Original Assignee
Morphochem Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphochem Ag filed Critical Morphochem Ag
Publication of IL150100A0 publication Critical patent/IL150100A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL15010001A 2000-01-17 2001-01-15 Pharmaceutical compositions containing fused cyclic compounds IL150100A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10001729A DE10001729A1 (de) 2000-01-17 2000-01-17 Verwendung spezieller Verbindungen zur Prophylaxe und Therapie von Hepatitis C
PCT/EP2001/000390 WO2001052824A2 (fr) 2000-01-17 2001-01-15 Utilisation de composes speciaux pour la prophylaxie et la therapie de l'hepatite c

Publications (1)

Publication Number Publication Date
IL150100A0 true IL150100A0 (en) 2002-12-01

Family

ID=7627769

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15010001A IL150100A0 (en) 2000-01-17 2001-01-15 Pharmaceutical compositions containing fused cyclic compounds

Country Status (8)

Country Link
EP (1) EP1248603B1 (fr)
JP (1) JP2003520225A (fr)
AT (1) ATE279182T1 (fr)
AU (1) AU3730201A (fr)
CA (1) CA2393694A1 (fr)
DE (2) DE10001729A1 (fr)
IL (1) IL150100A0 (fr)
WO (1) WO2001052824A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031011A1 (it) * 2003-05-20 2004-11-21 Vanetta S P A Composti biocidi per il trattamento delle acque.
CN1946385A (zh) * 2004-02-20 2007-04-11 罗伯特·F·霍夫曼 靶向氧化治疗制剂在治疗病毒性疾病中的用途
US20070141137A1 (en) * 2004-03-04 2007-06-21 Naoki Nagahara Stable capsule preparation
GB0806794D0 (en) * 2008-04-15 2008-05-14 Ludwig Inst Cancer Res Therapeutic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502008A1 (fr) * 1981-03-19 1982-09-24 Chekroun Mehir Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DK196688A (da) * 1987-04-28 1988-10-29 Fujisawa Pharmaceutical Co Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
US6080791A (en) * 1992-07-24 2000-06-27 Seres Laboratories, Inc. Method of treating a viral condition by inhibiting membrane fusion
AU5157998A (en) * 1996-11-01 1998-05-29 Thomas Najarian Methods and compositions for treatment of hepatitis c infection

Also Published As

Publication number Publication date
JP2003520225A (ja) 2003-07-02
DE10001729A1 (de) 2001-07-26
DE50104100D1 (de) 2004-11-18
WO2001052824A3 (fr) 2002-03-07
EP1248603B1 (fr) 2004-10-13
AU3730201A (en) 2001-07-31
ATE279182T1 (de) 2004-10-15
WO2001052824A2 (fr) 2001-07-26
EP1248603A2 (fr) 2002-10-16
CA2393694A1 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
IL150650A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
IL154893A0 (en) Aliphatic nitrogen-containing cyclic compounds, methods for the preparation thereof and pharmaceutical compositions containing the same
NL350075I2 (fr)
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
MXPA03007249A (es) Compuestos triazolo como inhibidores de mmp.
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
BG107120A (bg) Нови бавнодействащи бетамиметици, метод за тяхното получаване и приложението им като лекарствени средства
AP1541A (en) New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
MY126917A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
ZA9610418B (en) Phenylimidazolidines containing in particular a nitrooxy or carbonyloxy radical, preparation process and intermediates, use as medicaments, new uses and pharmaceutical compositions.
PT849269E (pt) Vinil-pirrolidina cefalosporinas com substituintes basicos
BG100884A (en) Benzamide derivative, compositions containing said derivative and use thereof
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
MY129094A (en) Condensed polycyclic compounds
WO2001052824A3 (fr) Utilisation de composes speciaux pour la prophylaxie et la therapie de l'hepatite c
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
GB0127568D0 (en) Chemical compounds
MY136065A (en) Prodrugs to nmda receptor ligands
MY133207A (en) Substituted benzolactam compaunds
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие